about
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio...
Read More
11.78
0.28
(2.43%)
22,973.6
XNAS Volume
XNAS 21 Jul, 2026 10:17 AM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Korro Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..